Clinical implications of dysbiosis in Autism Spectrum Disorder

Camila Tamara Pereira de Arruda and Patricia Susana Salguero

South Health and Policy, 2024, vol. 3, 108-108

Abstract: Autism Spectrum Disorder (ASD) has been addressed as a challenge in the field of neurodevelopment due to its clinical and etiological complexity. In recent years, interest in non-traditional factors, such as the gut microbiota, has intensified, with its influence on the microbiota-gut-brain axis being the subject of multiple studies. Microbial alterations have been documented in people with ASD, which have been linked to gastrointestinal and behavioural symptoms. Therapies such as probiotics, specific diets and faecal transfer have also been explored, showing clinical improvements in some cases. However, the causal relationship between dysbiosis and ASD remained under debate, highlighting the need for more rigorous studies to understand this complex interaction.

Date: 2024
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:southh:2024v3a65

DOI: 10.56294/shp2024108

Access Statistics for this article

More articles in South Health and Policy from AG Editor (Argentina)
Bibliographic data for series maintained by Javier Gonzalez-Argote ().